Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pirfenidone vs Placebo in Progressive Pulmonary Fibrosis
KCT0009628Phase 4Not yet recruiting
- Sponsor
- Kolon Life Science Inc.
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pirfenidone in pulmonary fibrosis (PF), sponsored by Kolon Life Science Inc.. Planned start Dec 2024; status: not yet recruiting.
02
Drugs
pirfenidone
03
Conditions
pulmonary fibrosis (PF)
Beyond the preview
Go deeper on KCT0009628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0009628.